Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

3 terminated/withdrawn out of 18 trials

Success Rate

81.3%

-5.3% vs industry average

Late-Stage Pipeline

11%

2 trials in Phase 3/4

Results Transparency

38%

5 of 13 completed trials have results

Key Signals

5 with results

Enrollment Performance

Analytics

N/A
6(75.0%)
Phase 4
2(25.0%)
8Total
N/A(6)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (18)

Showing 18 of 18 trials
NCT02913872Completed

Childhood Asthma Management in Primary Care: Implementation Of Exhaled Nitric Oxide and Spirometry Testing

Role: collaborator

NCT00562991Completed

Monitoring Asthma Treatment Using Exhaled Nitric Oxide

Role: collaborator

NCT02205723Not ApplicableWithdrawn

Smartphone-facilitated Asthma Control

Role: collaborator

NCT02717689Not ApplicableCompleted

A Pragmatic Trial of Corticosteroid Optimisation in Severe Asthma

Role: collaborator

NCT02424136Not ApplicableCompleted

PEAnut Anaphylaxis Predictors

Role: collaborator

NCT01783132Not ApplicableTerminated

Optimization of Inhaled Corticosteroid Treatment in Adult Patients With Asthma Guided by Exhaled NO Measurement at Home

Role: collaborator

NCT02479074Phase 4Completed

The Utility of feNO in the Differential Diagnosis of Chronic Cough

Role: collaborator

NCT01761006Terminated

Evaluation of FeNO During and Following Acute COPD Exacerbation

Role: collaborator

NCT02661984Unknown

Measurement of FeNO in Young Children With the NIOX VERO

Role: lead

NCT02622061Completed

NIOX VERO Nasal Application in Primary Ciliary Dyskinesia

Role: lead

NCT02294279Phase 4Completed

The Evaluation of FeNO for Predicting Response to ICS in Subjects With Non-specific Respiratory Symptoms

Role: collaborator

NCT02140684Suspended

Exhaled Nitric Oxide in Asthma Management

Role: collaborator

NCT01648920Completed

A Study to Explore the Utility of Fractional Exhaled Nitric Oxide (FeNO) Compared With Methacholine Challenge (MCC) Testing in the Assessment of Patients With Suspected But Undiagnosed Asthma

Role: lead

NCT01729247Completed

Study to Evaluate the Impact of FeNO Assessments on Asthma Management Decisions in Subject 7 to 60 Years of Age

Role: lead

NCT01634620Completed

Use of FeNO to Identify Eosinophilic Inflammation in Patients Age 40 Years and Above With Chronic Obstructive Airways Disease

Role: lead

NCT01518322Completed

Impact of FeNO Measured With the NIOX MINO® Device in Identifying Asthma Among Patients With Prolonged Respiratory Symptoms

Role: lead

NCT00421018Not ApplicableCompleted

Optimization of Asthma Treatment Through Exhaled NO for Increased Asthma-Related Quality of Life (NOAK)

Role: collaborator

NCT00388570Not ApplicableCompleted

Study of Monitoring Exhaled NO in Symptomatic Asthmatic Adults and Children During Anti-inflammatory Treatment

Role: lead

All 18 trials loaded